We are live on ! Find out more
BSX icon

Boston Scientific

877 hedge funds and large institutions have $56.3B invested in Boston Scientific in 2021 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 342 increasing their positions, 286 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more funds holding in top 10

Funds holding in top 10: 811 (+3)

31% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 62

20% more repeat investments, than reductions

Existing positions increased: 342 | Existing positions reduced: 286

1% more funds holding

Funds holding: 867877 (+10)

2% more capital invested

Capital invested by funds: $55.3B → $56.3B (+$970M)

0.38% more ownership

Funds ownership: 91.12%91.5% (+0.38%)

37% less call options, than puts

Call options by funds: $299M | Put options by funds: $477M

Holders
877
Holders Change
+10
Holders Change %
+1.15%
% of All Funds
15.35%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.19%
New
81
Increased
342
Reduced
286
Closed
62
Calls
$299M
Puts
$477M
Net Calls
-$178M
Net Calls Change
-$149M
Name Holding Trade Value Shares
Change
Change in
Stake
CAL
351
Capital Analysts LLC
Pennsylvania
$2.31M +$92.8K +2,097 +4%
HFS
352
Hantz Financial Services
Michigan
$2.3M +$345K +7,808 +17%
Los Angeles Capital Management
353
Los Angeles Capital Management
California
$2.21M +$311K +7,033 +16%
PTC
354
Private Trust Company
Ohio
$2.17M -$17.9K -405 -0.8%
SG
355
Somerset Group
Minnesota
$2.15M
PAM
356
Panagora Asset Management
Massachusetts
$2.14M -$30.4K -688 -1%
CA
357
Capitolis Advisors
New York
$2.12M -$603K -13,623 -22%
CIC
358
Cornercap Investment Counsel
Georgia
$2.05M +$2.09M +47,205 New
Rockefeller Capital Management
359
Rockefeller Capital Management
New York
$2.04M +$534K +12,069 +35%
RE
360
RBC Europe
United Kingdom
$2.04M +$112K +2,531 +6%
SLI
361
Sumitomo Life Insurance
Japan
$2.01M -$86.6K -1,957 -4%
GIM
362
Goelzer Investment Management
Indiana
$2M -$96.1K -2,173 -4%
IAS
363
IMA Advisory Services
Colorado
$2M -$12.7K -288 -0.6%
RWM
364
RBA Wealth Management
California
$1.98M +$75K +1,696 +4%
Rafferty Asset Management
365
Rafferty Asset Management
New York
$1.97M +$707K +15,985 +54%
OAM
366
Oppenheimer Asset Management
New York
$1.97M +$1.27M +28,627 +171%
BF
367
BOK Financial
Oklahoma
$1.95M +$1.99M +45,030 New
SEC
368
Seven Eight Capital
New York
$1.95M -$3.21M -72,561 -62%
WAOTB
369
Wealth Advisors of Tampa Bay
Florida
$1.92M +$70K +1,583 +4%
CI
370
Cigna Investments
Connecticut
$1.89M -$32.9K -744 -2%
HT
371
HAP Trading
New York
$1.87M -$483K -10,919 -20%
PP
372
Prudential plc
United Kingdom
$1.85M +$1.89M +42,648 New
PI
373
PineBridge Investments
New York
$1.84M +$1.87M +42,198 +16,679%
AC
374
Allstate Corporation
Illinois
$1.82M -$149K -3,372 -7%
BCM
375
Bayesian Capital Management
New York
$1.8M +$1.22M +27,600 +200%

BSX Hedge Fund Activity: Q3 2021 in Review

877 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2021, worth a combined $56.3B — up 1.8% from $55.3B a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new BSX positions and 62 closed out — a net gain of 19 holders — while 342 added to existing stakes and 286 trimmed.

The largest buyer was BlackRock, adding an estimated $202M. The largest seller was Viking Global Investors, cutting an estimated $285M.

  • 877 institutional investors held Boston Scientific (BSX) as of Q3 2021, up from 867 in Q2 2021.
  • Funds reported $56.3B of Boston Scientific stock for Q3 2021, up 1.8% quarter-over-quarter.
  • 81 funds opened new Boston Scientific positions in Q3 2021 and 62 closed out, a net change of +19 holders.
  • The largest Boston Scientific buyer in Q3 2021 was BlackRock, an estimated $202M added.
  • The largest Boston Scientific seller in Q3 2021 was Viking Global Investors, an estimated $285M sold.

Based on aggregated 13F filings for Q3 2021.